Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseM Bossard, P Gao, W Boden et al. -
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall shortCosta F, Valgimigli M.
-
Ticagrelor with or without Aspirin in High-Risk Patients after PCIR Mehran, U Baber, SK Sharma et al.
-
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsMauri L, Kereiakes DJ, DAPT Study Investigators.
-
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS studyChen Y, Yin T, Xi S et al.
-
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSS Anand, JW Eikelboom, COMPASS Trial Investigators.
-
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIK Takahashi, PW Serruys, P Chichareont et al.
-
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAJ Kirtane, R Stoler, R Feldman et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
